Tukysa150 mg Tablets Side Effects & Price

 Tukysa (tucatinib) is a prescription medication used to treat HER2-positive breast cancer. It is taken orally in the form of tablets.


The recommended dosage of Tukysa is 300 mg taken orally twice daily (total of 600 mg per day) in combination with trastuzumab and capecitabine, two other medications used to treat breast cancer. Treatment with Tukysa may continue as long as the patient continues to benefit from it and does not experience unacceptable side effects.


Tukysa works by inhibiting the growth of HER2-positive breast cancer cells. HER2 is a protein that promotes the growth and division of cancer cells. By blocking the activity of HER2, Tukysa can slow down or stop the growth of the cancer cells.


Common side effects of Tukysa include diarrhea, nausea, vomiting, fatigue, and liver problems. Tukysa can also cause serious side effects, such as severe diarrhea, liver problems, and lung problems. Patients should inform their healthcare provider immediately if they experience any of these symptoms or side effects.


It is important to discuss any potential risks and benefits of Tukysa with your healthcare provider before starting treatment. You should also inform your healthcare provider if you have a history of liver or lung problems, as well as any medications you are currently taking.

Comments

Popular posts from this blog

Tofacitinib Tablet 5 mg , Price & side Effects

Carfilzomib Injection 60 mg Price & Side Effects

Enhertu Injection 100 mg Price & Side Effects